Testing Next-Generation heart pacemaker technology
NCT ID NCT06620237
Summary
This study is testing the safety and performance of a new pacemaker system (Amvia pacemaker with Solia CSP S lead) for people who need heart rhythm treatment. The research involves 152 participants in Europe, Australia, and New Zealand who will be followed for up to 12 months after implantation. The goal is to see if this new system works safely and effectively for a specific type of heart pacing called left bundle branch area pacing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Sint-Jan
Bruges, 8000, Belgium
-
Auckland City Hospital
Grafton, 1023, New Zealand
-
Catharina Ziekenhuis
Eindhoven, 5623 EJ, Netherlands
-
Centre Hospitalier Metz-Thionville
Metz, 57038, France
-
Clinique Saint-Pierre Ottignies
Ottignies, 1340, Belgium
-
Grand Hôpital de Charleroi
Charleroi, 6060, Belgium
-
Hopital de la Timone (CHU La Timone)
Marseille, 13005, France
-
Hôpital Haut Lévêque (CHU)
Pessac, 33600, France
-
Hôpital privé du Confluent
Nantes, 44277, France
-
Integral Healthcare
Adelaide, 5068, Australia
-
Lyell McEwin Hospital
Elizabeth Vale, 5112, Australia
-
Noordwest Ziekenhuisgroep
Alkmaar, 1815 JD, Netherlands
-
UZ Gent - Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Victorian Heart Hospital
Clayton, 3168, Australia
Conditions
Explore the condition pages connected to this study.